suberoyl bis-hydroxamic acid has been researched along with Argentaffinoma in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
Excerpt | Relevance | Reference |
---|---|---|
"Gastrointestinal and pulmonary carcinoid cells were treated with either VPA or SBHA and lithium chloride for up to 48 hours." | 5.35 | Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors. ( Adler, JT; Chen, H; Hottinger, DG; Kunnimalaiyaan, M, 2009) |
"Gastrointestinal and pulmonary carcinoid cells were treated with either VPA or SBHA and lithium chloride for up to 48 hours." | 1.35 | Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors. ( Adler, JT; Chen, H; Hottinger, DG; Kunnimalaiyaan, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, JT | 1 |
Hottinger, DG | 1 |
Kunnimalaiyaan, M | 1 |
Chen, H | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Argentaffinoma
Article | Year |
---|---|
Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoid | 2009 |